BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd. Xianyang Yongsheng has three production lines, including health “Yuye” wine” (a popular brand in the PRC market), tea and capsules, and maintains a 24-acre Chinese herbal medicine ecological park. Mr. Wang Ronghua, the Chairman of Biostar, commented, “We have been following the developments of the] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): September 7, 2016 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ☐ ☐ ☐]

By | 2016-09-23T03:05:21+00:00 September 22nd, 2016|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

JFC [JPMORGAN CHINA REGION FUND] 8-K: (Original Filing)

[Fund information Portfolio (as at 31/08/16) Share price USD 17.03 NAV per share USD 18.68 Discount (-) / Premium Current -8.8! Shares in issue 6,447,637 Fund code Bloomberg JFC US ISIN US46614T1079 Sedol 2471392 Fund % 19.5% 16.3% 14.5% 13.2% 11.7% 10.7% 6.8% 0.0% 7.3% 100.0% Portfolio review China - ‘A’ Shares Hong Kong Taiwan China - Hong Kong ‘P] []

By | 2016-09-22T14:46:40+00:00 September 22nd, 2016|Categories: Chinese Stocks, JFC, SEC Original|Tags: , , , |0 Comments
Read More

SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] 6-K: (Original Filing)

[CONTENTS 2 Additional Information 3 Corporate Information 4 Letter to Shareholders 6 Management’s Discussion and Analysis of Financial Condition and Results of Operations 16 Corporate Governance Report 26 Other Information 34 Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 35 Condensed Consolidated Statements of Financial Position 36 Condensed Consolidated Statements of Changes in Equity 37 Condensed Consolidated]

By | 2016-09-22T14:48:47+00:00 September 22nd, 2016|Categories: Chinese Stocks, SEC Original, SMI|Tags: , , , , , |0 Comments
Read More

CEA [CHINA EASTERN AIRLINES] 6-K: (Original Filing)

[(A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 00670) WORLD – CLASS Hospitality with Eastern Charm INTERIM REPORT 2016 This interim report is printed on environmentally friendly paper The directors of China Eastern Airlines Corporation Limited (the “Company”) hereby present the unaudited interim consolidated financial information of the Company and its] []

By | 2016-09-21T18:23:26+00:00 September 21st, 2016|Categories: CEA, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

SGOC [SGOCO] 6-K: (Original Filing)

[SGOCO Group, Ltd. Appoints DCAW (CPA) Limited as Its New Independent Registered Public Accounting Firm Hong Kong, September 21, 2016 /PRNewswire/ -- SGOCO Group, Ltd. (Nasdaq: SGOC) ("SGOCO" or the "Company"), a company focused on product design, distribution and brand development in the Chinese display and computer product market as well as energy saving products and services, today announced the] [Our Ref: SCH1709 / SS / KL / A18 / CH1506 / 16 September 21, 2016 100 F Street, NE Ladies and Gentlemen: Very truly yours Crowe Horwath (HK) CPA Limited Hong Kong, China] []

By | 2016-09-21T18:31:00+00:00 September 21st, 2016|Categories: Chinese Stocks, SEC Original, SGOC|Tags: , , , , , |0 Comments
Read More

CO [China Cord Blood] F-3: (Original Filing)

[FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHINA CORD BLOOD CORPORATION Cayman Islands Not Applicable (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) th 48 Law Debenture Corporate Services, Inc. (Name, address and telephone number of agent for service) with a copy to: Mitchell S. Nussbaum, Esq. From time to time after the] [21 September 2016 Matter No.: 822741 Doc Ref: RJH/102777384v1 Tel No.: 852 2842 9530 E-mail: Richard.Hall@conyersdill.com China Cord Blood Corporation 48 th 1 Garden Road, Central Hong Kong S.A.R. Dear Sirs, Re: China Cord Blood Corporation (the “Company”) Registration Statement Commission Securities Act Ordinary Shares Preferred Shares Equity Securities Debt Securities Rights Units Securities We have acted as special Cayman] [345 Park Avenue New York, NY 10154-1895 Direct Main Fax September 21, 2016 China Cord Blood Corporation 48 th 1 Garden Road Central, Hong Kong, S.A.R. Re: Registration Statement on Form F-3 Ladies and Gentlemen: China Cord Blood Corporation September 21, 2016 Page 2] [RATIO OF EARNINGS TO FIXED CHARGES CCBC’s ratio of earnings to fixed charges for each of the periods indicated is set forth below. We have derived the ratios of earnings to fixed charges from our historical consolidated financial statements. The ratios should be read in conjunction with our consolidated financial statements, including the notes thereto, and the other financial information] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: We consent to the use of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31, 2015, and the related consolidated statements of comprehensive income, changes in equity, and cash flows] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: We consent to the use of our reports dated July 28, 2016, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31, 2016, and the related consolidated statements of comprehensive income, changes in equity, and cash flows] [China Cord Blood Corporation Central Hong Kong S.A.R. Madams and Sirs, EX-23.5 7 a16-18402_1ex23d5.htm EX-23.5]

By | 2016-09-22T02:11:58+00:00 September 21st, 2016|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments
Read More

DANG [E-COMMERCE CHINA DANGDANG] 25-NSE: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;} .FormNumText {font-size: small; font-weight: bold; font-family:] []

By | 2016-09-22T02:18:03+00:00 September 21st, 2016|Categories: Chinese Stocks, DANG, SEC Original|Tags: , , , , , |0 Comments
Read More

CHU [CHINA UNICOM (HONG KONG)] 6-K: (Original Filing)

[1 Announcement dated September 19, 2016 in respect of Operational Statistics for August 2016. • • changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunications services by the central government of the PRC; • changes in telecommunications and related technologies and applications based on such technologies; • the level of demand for telecommunications services, in]

By | 2016-09-21T18:33:20+00:00 September 20th, 2016|Categories: Chinese Stocks, CHU, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar